Learn about published research as well as leading-edge basic and translational research initiatives from St. Jude laboratories.
Researchers are focusing on treatment-related pain as another way to reduce the risk of learning and memory problems in survivors of childhood leukemia.
St. Jude scientists have created an algorithm to help group T-cells by their function by evaluating two different types of data, T-cell receptor sequences and gene expression.
Description: St. Jude biostatisticians have developed a new method for designing phase 2 clinical trials with a small sample size. The approach uses a mathematical model called Bayesian probability . The researchers created free software to implement the process.
St. Jude will host the virtual Bringing Chemistry to Medicine Symposium July 22–23. The inaugural event in 2020 prompted a researcher in India to become a visiting scientist at St. Jude. Register for the event.
Kristin Lyons, director of Rehabilitation Services, and Jessica Sparrow, Lead Occupational Therapist, worked as part of a team of oncology rehabilitation providers from pediatric institutions across the country to co-author a recent Seminars in Oncology Nursing article, which provides a comprehensive overview of rehabilitation screening, assessment, and intervention for children with cancer.
Posterior fossa syndrome develops in some children following surgery for the brain tumor medulloblastoma. St. Jude research offers fresh insight into the mysterious syndrome and advice on how to avoid it.
As cancer survivorship changes, new benchmarks must be set to redefine survivorship research and treatment success.
Cancer treatments can result in damage to the heart both during treatment and years following completion of therapy. As many cancer survivors are now living longer into adulthood, we’re gaining a better understanding of some of the late effects of cancer treatments that we weren’t able to observe before.
Scientists are learning more about antibody production in response to flu, including how they develop from helper T cells and monocytes.
Genetic changes in the biology of blood cells can lead them down a path to cancer. This researcher is figuring out how that happens.